Altria Group Inc (MO) Stock News

Silicon Motion (SIMO) declined 8.36% in recent trading, underperforming the S&P 500's 0.47% loss. Despite a monthly gain of 2.91%, the stock lags its sector. Analysts expect strong earnings growth of 230% YoY and revenue growth of 120.17%, with full-year projections showing 214.37% earnings growth. The stock holds a Zacks Rank #3 (Hold) with a Forward P/E of 25.62, trading at a premium to its industry average.

Regeneron announced presentations of new clinical research at ESMO Congress 2026, highlighting late-breaking Phase 3 data for Libtayo (cemiplimab) in cutaneous squamous cell carcinoma, Phase 2 neoadjuvant treatment data, and new research on Factor XI antibodies for cancer-associated thrombosis. The company is presenting 10 abstracts covering trials in CSCC, NSCLC, ovarian cancer, melanoma, and cancer-associated thrombosis.

The global cell and gene therapy biomanufacturing market is projected to grow from $5.0 billion in 2026 to $8.7 billion by 2031, driven by an 11.7% CAGR. Growth is fueled by increasing regulatory approvals, rising demand for scalable manufacturing infrastructure, and investments in automation and modular systems. However, high production costs, regulatory complexity, and workforce shortages remain significant challenges.

A class action lawsuit has been filed against Replimune Group Inc. for allegedly making materially false statements regarding its Biologics License Application (BLA). The lawsuit claims the company failed to disclose that FDA study design concerns were not addressed and that submitted data from an early analysis included only 40 of 400 planned patients, likely causing FDA rejection of the BLA. Investors who purchased securities between October 20, 2025 and April 10, 2026 can apply to be lead plaintiff by October 5, 2026.

A class action lawsuit has been filed against ARS Pharmaceuticals for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product (neffy) with CVS Caremark. The company reportedly expressed confidence that coverage would begin July 1, 2026, while failing to adequately disclose risks that the deadline might not be met, potentially impacting summer and back-to-school sales.

A class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) for allegedly making false and misleading statements regarding revenue recognition and announcing transactions with unequipped entities to create an appearance of growth. Investors who purchased Blaize securities between July 17, 2025 and August 13, 2026 have until October 5, 2026 to apply as lead plaintiff.

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement.

Silicon Motion (SIMO) outperformed the broader market on September 30, 2026, closing up 1.39% while the S&P 500 declined 0.25%. The stock has gained 16.35% over the past month and is forecasted to report strong earnings with EPS expected at $3.3 (up 230% YoY) and revenue of $532.81 million (up 120% YoY). SIMO holds a Zacks Rank #1 (Strong Buy) rating with a PEG ratio of 0.46, though it trades at a Forward P/E of 24.76, above its industry average.

Altria (MO) is trending among investors but faces headwinds according to Zacks analysis. The stock has underperformed the S&P 500 over the past month (-1.2% vs -0.4%). While earnings estimates remain stable with modest growth projections (4.6% for current fiscal year, 3% for next year), Altria received a Zacks Rank #4 (Sell) rating, suggesting it may underperform the broader market in the near term. The company trades at par with peers based on valuation metrics.

Modine Manufacturing (MOD), a heating and cooling products maker, is attracting investor attention with strong earnings growth expectations. The company is projected to report 37.7% year-over-year earnings growth for the current quarter and 52.4% for the fiscal year. However, it maintains a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market in the near term. The stock trades at par with its peers based on valuation metrics.

Galaxy Gaming announced that its MONOPOLY Table Games Progressive has won Product Innovation of the Year at the Global Gaming Awards Americas 2026. The linked progressive table game, developed through an exclusive licensing agreement with Hasbro, has achieved widespread installations across North America and EMEA. Galaxy Gaming is showcasing new MONOPOLY-branded games and Galaxy Link technology at G2E 2026.

The global microporous materials market is projected to grow from $5.9 billion in 2024 to $7.2 billion by 2030, expanding at a 3.2% CAGR. Growth is driven by rising demand for carbon capture, clean fuels, purification, and advanced manufacturing applications. Key players including BASF, Honeywell UOP, Albemarle, and Evonik are accelerating development of metal-organic frameworks (MOFs) and carbon-capture technologies. Asia-Pacific, particularly China, is expected to see strong growth at 5.8% CAGR.

L'Oréal completed a successful bond issuance of €2 billion across three tranches on September 24, 2026: €850 million at 2 years with variable rate (Euribor 3M + 27 bp), €500 million at 3 years at 3.75% fixed, and €650 million at 7 years at 4.00% fixed. The bonds are expected to be rated AA (Stable) by S&P and Aa1 (Stable) by Moody's, with listing on Euronext Paris on September 30, 2026.

HUTCHMED announced that two Phase III studies evaluating the savolitinib and osimertinib combination for non-small cell lung cancer will be presented at ESMO Congress 2026 in Madrid. The SAFFRON global study and SANOVO China study both demonstrated statistically significant and clinically meaningful improvements in progression-free survival and overall survival compared to chemotherapy and osimertinib monotherapy, respectively. The all-oral, chemo-free combination has been selected for high-profile oral presentations including a Presidential Symposium.

Swarmer, Inc. announced a nonbinding memorandum of understanding with Vectus Air Defense Systems to manufacture end-to-end air defense systems in Poland. Vectus has confirmed intent to purchase at least 40 systems in year one and 80+ in year two, with each system retailing at approximately $5-6 million. The systems will feature combat-proven 20mm rotary cannons capable of firing 6,000 rounds per minute, designed to provide cost-effective air defense against drone threats.

UnitedHealth Group (UNH) and Molina Healthcare (MOH) are compared as investment options in the managed care sector. UNH benefits from diversification through its Optum platform, improving profitability, and a stronger balance sheet, but faces membership pressure. MOH offers a focused recovery story with stabilizing Medicaid economics and growth in Medicare dual-eligible plans, commanding a higher valuation. Despite UNH's operational strengths, MOH is rated as the more attractive investment due to stronger projected earnings rebound, earning a Zacks Rank #1 (Strong Buy) versus UNH's Rank #2 (Buy).

The VanEck Morningstar Wide Moat ETF (MOAT) is a passively managed large-cap blend ETF with $14.58 billion in assets. It returned 4.86% year-to-date and 10.95% over the past year with a 0.46% expense ratio. The fund holds 57 companies with heavy exposure to Information Technology (26.7%), and carries a Zacks ETF Rank of 3 (Hold). Alternatives like IVV and VOO offer lower expense ratios of 0.03%.

While Wall Street analysts give Modine (MOD) a strong buy recommendation with an average brokerage rating of 1.20, the article cautions that brokerage recommendations often have a positive bias due to vested interests. Modine's Zacks Rank of #3 (Hold) suggests investors should be cautious, as the consensus earnings estimate has remained unchanged at $7.65, indicating the stock may perform in line with the broader market.

A two-day online training course on managing Contract Research Organisations (CROs) and Contract Manufacturing Organisations (CMOs) under ICH GCP R3 guidelines will be delivered by IPI Academy on October 14-15, 2027. The course addresses sponsor oversight, vendor selection, risk-based management, and regulatory compliance expectations for pharmaceutical and biotech organisations.

A securities class action lawsuit has been filed against AST SpaceMobile, Inc. on behalf of investors who purchased securities between March 4, 2025 and July 15, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the company's business operations, growth prospects, and financial stability, causing AST securities to trade at artificially inflated prices. Investors who suffered losses are encouraged to contact Bernstein Liebhard LLP, with a lead plaintiff deadline of November 13, 2026.

The Invesco S&P SmallCap Momentum ETF (XSMO) offers exposure to small-cap growth stocks with $2.91 billion in assets and a 0.36% expense ratio. The ETF has returned 14.62% year-to-date and 13.13% over the past year, with a beta of 1.08 and 109 holdings. It carries a Zacks ETF Rank of 3 (Hold), positioning it as a sufficient option for small-cap growth investors, though competitors like Vanguard Morningstar Small-Cap Growth ETF (VBK) offer lower expense ratios.

Altria (MO) outperformed the broader market on September 14, 2026, closing up 2.4% while the S&P 500 declined 0.48%. The stock has gained 4.99% over the past month. Upcoming Q3 earnings are expected on October 29, 2026, with projected EPS of $1.5 (up 3.45% YoY) and revenue of $5.33 billion (up 1.49% YoY). The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.16, trading at a discount to its industry average of 14.21.

Modine Manufacturing ended trading down 3.76%, outpacing the broader market decline. Despite the recent pullback, the company shows strong growth prospects with expected EPS growth of 37.74% and revenue growth of 30.55% for the upcoming quarter. However, the stock trades at a premium valuation with a Forward P/E of 24.75 versus its industry average of 13.28, and holds a Zacks Rank #3 (Hold) rating.

Morningstar is projected to reach a market value of $13.2 billion within five years, representing a 73% increase from its recent $7.5 billion valuation. The company has demonstrated consistent 12% annual revenue growth, currently trades at undervalued P/E and price-to-sales ratios, and offers an attractive 13.2% total shareholder yield including dividends and buybacks.

Micware Co., Ltd. and MulticoreWare, Inc. have signed a Memorandum of Understanding to explore collaboration on AI solutions for advanced driver assistance systems (ADAS), in-vehicle user experience, and edge AI. The partnership combines Micware's automotive OEM relationships and software expertise with MulticoreWare's capabilities in heterogeneous hardware optimization and AI integration. The MOU, effective until June 8, 2027, covers technical cooperation, physical AI integration, business development in Japan, and joint marketing activities, though no definitive agreements have been concluded.

OMODA, as the exclusive Official Automobile Partner of VCT EMEA, showcased the OMODA 4 Cyber Mecha at the VALORANT Champions Tour EMEA finals in Barcelona. The vehicle features a co-branded wrap with esports aesthetics and AI Intelligent Cockpit technology, targeting Gen Z consumers. OMODA & JAECOO announced plans for a major debut at the Paris Motor Show on October 12, 2026, unveiling an AI dream car. The brand has achieved one million in sales within three years and expanded to 77 markets globally.

Thermo Fisher Scientific unveiled the EMPAD G2 detector, enabling faster 4D STEM materials analysis at 10,000 frames per second with atomic-scale characterization. The detector integrates with Velox software for simplified analysis. The global 4D STEM market is projected to grow from $68 million in 2024 to $110 million by 2031 at a 6.6% CAGR, supporting TMO's growth prospects in analytical instruments.

Silicon Motion (SIMO) has received overwhelmingly bullish recommendations from Wall Street analysts with an average brokerage recommendation of 1.09 (Strong Buy), with 10 out of 11 firms rating it Strong Buy. The company's Zacks Rank #1 (Strong Buy) rating is supported by a 2.6% increase in consensus earnings estimates over the past month to $11.16 EPS, indicating growing analyst optimism about the company's earnings prospects.

The global MMORPG gaming market is projected to grow from $31.02 billion in 2026 to $51.3 billion by 2031 at a 10.58% CAGR. Growth is driven by smartphone adoption in emerging markets, 5G/cloud gaming technology, and free-to-play hybrid models with season passes. However, high development costs and regulatory scrutiny on loot boxes remain key challenges. Mobile platforms and Asia-Pacific regions are leading growth.

UMH Properties secured a new $10.2 million Fannie Mae mortgage at 6.03% fixed rate for a 267-site community through Wells Fargo. After paying off a $2.8 million existing mortgage, the company generated $7.4 million in additional proceeds to deploy toward acquisitions, expansions, rental homes, and debt repayment. The community has been improved from 69% to 95% occupancy since acquisition in 2014.